Month: September 2016
-
Monsanto Licensing MIT/Harvard Genome Editing
Monsanto Company is licensing genomic editing technology for agricultural applications from a joint research center at Harvard University and MIT.
-
Malnutrition Shown Adding Billions to U.S. Health Costs
An analysis of data from health surveys shows malnutrition associated with 8 common chronic diseases adds $15.5 billion directly to U.S. health care costs.
-
Antibiotic Shown to Control Drug-Resistant Gonorrhea
Findings from a clinical trial show a candidate drug kills bacteria causing a type of gonorrhea becoming resistant to current antibiotics.
-
Genentech, BioNTech Partner on Personal Cancer Therapies
Biotechnology company BioNTech AG is licensing its messenger RNA technology and collaborating with biopharmaceutical company Genentech to develop personalized cancer immunotherapies.
-
Health Agency Funds Drug-Resistant Bacteria R&D
Biomedical Advanced Research and Development Authority, or BARDA, signed agreements worth $67 million to develop new treatments and diagnostics for urgent drug-resistant infections.
-
Clinical Trial Testing Live Bacteria as Acne Treatment
A clinical trial is recruiting participants to test a product with live skin bacteria made by biotechnology company AOBiome as a treatment for adult acne.
-
Teva Licenses Pain Relief Antibody for $1.25 Billion
Teva Pharmaceutical Industries is licensing from biotechnology company Regeneron Pharmaceuticals an engineered antibody that targets proteins supporting pain signals.
-
FDA Holding Opioid Overdose App Competition
The U.S. Food and Drug Administration is seeking a smartphone app that can quickly find a source of the antidote drug naloxone for someone having an opioid overdose.
-
Drug Shown to Improve Cell Energy, Muscle Function
Results of a clinical trial show an experimental drug by Stealth BioTherapeutics boosts cellular energy and improves skeletal muscle functions of older adults.
-
St. Jude, Sanger Institute to Share Genomic Databases
Two research institutes — St. Jude Children’s Research Hospital and Wellcome Trust Sanger Institute — will share their databases on cancer genomics with the other institution’s scientists.